Literature DB >> 3899429

Acute malaria prolongs susceptibility of mice to Plasmodium berghei sporozoite infection.

A U Orjih.   

Abstract

The fate of immune response against sporozoite stage in malaria infection was investigated. Two groups (A and B) of mice were inoculated twice with infective sporozoites of Plasmodium berghei. The mice in group A were maintained on chloroquine prophylaxis to prevent the sporozoite infection from causing malaria. Group B animals on the other hand were allowed to develop acute malaria from the infection which was subsequently cured with chloroquine. Upon examination for stage specific immune responses, it was found that the animals in group A produced high antibody titres against sporozoites and none against erythrocytic stages. The mice in group B produced little anti-sporozoite antibodies but had high antibody titres against blood forms. Challenge infection with P. berghei sporozoites showed that group A animals had become resistant against sporozoite-induced parasitaemia, whereas the mice in group B remained susceptible. The possible significance of suppression of protective immunity by malaria in host-parasite relationship is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3899429      PMCID: PMC1577241     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Plasmodium berghei: suppression of antibody response to sporozoite stage by acute blood stage infection.

Authors:  A U Orjih; R S Nussenzweig
Journal:  Clin Exp Immunol       Date:  1979-10       Impact factor: 4.330

2.  Immunosuppression in murine malaria. I. General characteristics.

Authors:  B M Greenwood; J H Playfair; G Torrigiani
Journal:  Clin Exp Immunol       Date:  1971-03       Impact factor: 4.330

Review 3.  Etiology of Burkitt's lymphoma--an alternative hypothesis to a vectored virus.

Authors:  D P Burkitt
Journal:  J Natl Cancer Inst       Date:  1969-01       Impact factor: 13.506

4.  Further studies on the Plasmodium berghei-Anopheles stephensi--rodent system of mammalian malaria.

Authors:  J P Vanderberg; R S Nussenzweig; H Most
Journal:  J Parasitol       Date:  1968-10       Impact factor: 1.276

5.  Experimental malaria: effects upon the immune response to different antigens.

Authors:  L R Barker
Journal:  J Infect Dis       Date:  1971-01       Impact factor: 5.226

6.  Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite.

Authors:  N Yoshida; R S Nussenzweig; P Potocnjak; V Nussenzweig; M Aikawa
Journal:  Science       Date:  1980-01-04       Impact factor: 47.728

Review 7.  Immunity to malaria.

Authors:  S Cohen
Journal:  Proc R Soc Lond B Biol Sci       Date:  1979-01-15

8.  Sporozoites of rodent and simian malaria, purified by anion exchangers, retain their immunogenicity and infectivity.

Authors:  G Moser; F H Brohn; H D Danforth; R S Nussenzweig
Journal:  J Protozool       Date:  1978-02

9.  Antibodies to sporozoites: their frequent occurrence in individuals living in an area of hyperendemic malaria.

Authors:  E H Nardin; R S Nussenzweig; I A McGregor; J H Bryan
Journal:  Science       Date:  1979-11-02       Impact factor: 47.728

10.  Malaria antigen-specific T-cell responsiveness during infection with Plasmodium falciparum.

Authors:  D J Wyler; J Brown
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

View more
  6 in total

1.  Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage.

Authors:  Elodie Belnoue; Tatiana Voza; Fabio T M Costa; Anne Charlotte Grüner; Marjorie Mauduit; Daniela Santoro Rosa; Nadya Depinay; Michèle Kayibanda; Ana Margarida Vigário; Dominique Mazier; Georges Snounou; Photini Sinnis; Laurent Rénia
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

2.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

3.  Development of immunity in natural Plasmodium falciparum malaria: antibodies to the falciparum sporozoite vaccine 1 antigen (R32tet32).

Authors:  H K Webster; E F Boudreau; L W Pang; B Permpanich; P Sookto; R A Wirtz
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

4.  CD8(+) T cells mediate robust stage-specific immunity to P. berghei under chemoprophylaxis and this protective environment is not downregulated by the presence of blood-stage infection.

Authors:  Matthew D Lewis; Johannes Pfeil; Kirsten Heiss; Ann-Kristin Mueller
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240

5.  Studying the effect of chloroquine on sporozoite-induced protection and immune responses in Plasmodium berghei malaria.

Authors:  Else M Bijker; Krystelle Nganou-Makamdop; Geert-Jan van Gemert; Fidel Zavala; Ian Cockburn; Robert W Sauerwein
Journal:  Malar J       Date:  2015-03-26       Impact factor: 2.979

6.  Long term protection after immunization with P. berghei sporozoites correlates with sustained IFNγ responses of hepatic CD8+ memory T cells.

Authors:  Krystelle Nganou-Makamdop; Geert-Jan van Gemert; Theo Arens; Cornelus C Hermsen; Robert W Sauerwein
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.